• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.

作者信息

Saini Sarbjit S, Bindslev-Jensen Carsten, Maurer Marcus, Grob Jean-Jacques, Bülbül Baskan Emel, Bradley Mary S, Canvin Janice, Rahmaoui Abdelkader, Georgiou Panayiotis, Alpan Oral, Spector Sheldon, Rosén Karin

出版信息

J Invest Dermatol. 2015 Mar;135(3):925. doi: 10.1038/jid.2014.512. Epub 2014 Dec 11.

DOI:10.1038/jid.2014.512
PMID:25501032
Abstract
摘要

相似文献

1
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.奥马珠单抗在使用H1抗组胺药后仍有症状的慢性特发性/自发性荨麻疹患者中的疗效和安全性：一项随机、安慰剂对照研究。
J Invest Dermatol. 2015 Mar;135(3):925. doi: 10.1038/jid.2014.512. Epub 2014 Dec 11.
2
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.奥马珠单抗治疗标准联合治疗后仍有症状的慢性特发性/自发性荨麻疹患者。
J Allergy Clin Immunol. 2013 Jul;132(1):101-9. doi: 10.1016/j.jaci.2013.05.013.
3
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.一项奥马珠单抗单剂量、安慰剂对照、剂量范围研究，用于 H1 抗组胺药难治性慢性特发性荨麻疹患者。
J Allergy Clin Immunol. 2011 Sep;128(3):567-73.e1. doi: 10.1016/j.jaci.2011.06.010. Epub 2011 Jul 18.
4
Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.尽管基础治疗不同，但奥马珠单抗在慢性特发性/自发性荨麻疹中的疗效相似。
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):743-50.e1. doi: 10.1016/j.jaip.2015.04.015. Epub 2015 Jun 6.
5
Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria.慢性特发性/自发性荨麻疹患者奥马珠单抗应答的时间和持续时间。
J Allergy Clin Immunol. 2016 Feb;137(2):474-81. doi: 10.1016/j.jaci.2015.08.023. Epub 2015 Oct 21.
6
Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.使用奥马珠单抗治疗荨麻疹的临床管理：首个获批用于慢性自发性荨麻疹的生物疗法。
J Eur Acad Dermatol Venereol. 2016 Jul;30 Suppl 5:25-32. doi: 10.1111/jdv.13697.
7
A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria.甲氨蝶呤治疗H1抗组胺药耐药性慢性自发性荨麻疹的随机安慰剂对照双盲试验研究
Indian J Dermatol Venereol Leprol. 2014 Mar-Apr;80(2):122-8. doi: 10.4103/0378-6323.129382.
8
Omalizumab for the treatment of chronic urticaria.奥马珠单抗治疗慢性荨麻疹。
Expert Rev Clin Immunol. 2015 Feb;11(2):171-80. doi: 10.1586/1744666X.2015.993971. Epub 2015 Jan 7.
9
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.奥马珠单抗治疗针对甲状腺过氧化物酶的 IgE 的慢性荨麻疹患者的疗效和安全性。
J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.
10
Self-reported hair loss in patients with chronic spontaneous urticaria treated with omalizumab: an under-reported, transient side effect?接受奥马珠单抗治疗的慢性自发性荨麻疹患者自我报告的脱发：一种报告不足的短暂副作用？
Eur Ann Allergy Clin Immunol. 2016 Sep;48(5):205-7.

引用本文的文献

1
[Severe anaphylaxis following administration of omalizumab].使用奥马珠单抗后发生严重过敏反应
Dermatologie (Heidelb). 2025 Sep;76(9):578-580. doi: 10.1007/s00105-025-05542-9. Epub 2025 Jul 31.
2
Quality of life, sleep, and psychological well-being in chronic spontaneous urticaria patients receiving omalizumab: a case-control study.接受奥马珠单抗治疗的慢性自发性荨麻疹患者的生活质量、睡眠和心理健康：一项病例对照研究。
Arch Dermatol Res. 2025 Apr 17;317(1):715. doi: 10.1007/s00403-025-04231-w.
3
Vaccine-Induced Anti-IgE Antibodies Neutralize Free IgE but Fail to Bind and Activate Mast Cell-Displayed IgE.
疫苗诱导的抗IgE抗体可中和游离IgE，但无法结合并激活肥大细胞表面展示的IgE。
Allergy. 2025 Jul;80(7):1995-2007. doi: 10.1111/all.16530. Epub 2025 Apr 7.
4
Reduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding.通过增强与 FcγRIIb 结合的 pH 敏感型抗体降低循环 IgE 和过敏原。
Mol Ther. 2024 Oct 2;32(10):3729-3742. doi: 10.1016/j.ymthe.2024.08.029. Epub 2024 Sep 2.
5
Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?慢性自发性荨麻疹患者的血管性水肿是否会影响对奥马珠单抗的反应？
World Allergy Organ J. 2024 Aug 5;17(8):100943. doi: 10.1016/j.waojou.2024.100943. eCollection 2024 Aug.
6
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.奥马珠单抗治疗慢性自发性荨麻疹患者：现状的叙述性综述
Dermatol Ther (Heidelb). 2023 Nov;13(11):2573-2588. doi: 10.1007/s13555-023-01040-9. Epub 2023 Sep 30.
7
Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients.慢性自发性荨麻疹患者接受奥马珠单抗低剂量治疗的临床应答：179 例患者的回顾性研究。
Acta Derm Venereol. 2023 Aug 30;103:adv11627. doi: 10.2340/actadv.v103.11627.
8
IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance Fc Receptors.IgE 聚糖促进抗 IgE IgG 自身抗体，从而促进 IgE 血清清除 Fc 受体。
Front Immunol. 2022 Dec 2;13:1069100. doi: 10.3389/fimmu.2022.1069100. eCollection 2022.
9
Pathophysiology, Diagnosis, and Management of Chronic Spontaneous Urticaria: A Literature Review.慢性自发性荨麻疹的病理生理学、诊断和治疗：文献综述。
Clin Rev Allergy Immunol. 2022 Dec;63(3):381-389. doi: 10.1007/s12016-022-08952-y. Epub 2022 Sep 1.
10
Expert consensus on the use of omalizumab in chronic urticaria in China.中国奥马珠单抗治疗慢性荨麻疹专家共识
World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov.